10-KCCCCCIK 0001662579

C4 Therapeutics, Inc.

Name: SEC EDGAR filing 0001628280-26-012000
Creator: C4 Therapeutics, Inc.
License: https://www.usa.gov/government-works

Annual report (10-K) filed February 26, 2026.

Comprehensive annual report filed by U.S. public companies, including audited financial statements, MD&A, and risk factors.

Read the filing on SEC.gov All documents in this filing

New to the 10-K? What it is and how to read one

Filing facts

Accession number: 0001628280-26-012000
Filer: C4 Therapeutics, Inc.
Ticker: CCCC
CIK: 0001662579
Form type: 10-K
Form description: Annual report
Filed at: February 26, 2026
Period of report: December 31, 2025
Industry: SIC 2836Biological Products
Filing size: 12.0 MB
Last verified: August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from C4 Therapeutics, Inc.

See all 42 filings from C4 Therapeutics, Inc. →

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1662579/000162828026012000/0001628280-26-012000-index.htm ↗

Filer's full EDGAR submission history

EDGAR · C4 Therapeutics, Inc. (0001662579) ↗

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.